New research indicates that tests of patients' kidney health may provide insights on their risk of developing cardiovascular disease. The findings are published in an upcoming issue of JASN.
Mar 4, 2021
0
10
Molecules called microRNAs (miRNAs) that are measurable in urine have been identified by researchers at Mount Sinai as predictors of both heart and kidney health in children without disease. The epidemiological study of Mexican ...
Feb 26, 2021
0
3
(HealthDay)—Social deprivation is associated with diabetes-related foot disease (DFD) in patients newly diagnosed with type 2 diabetes, according to a study published online Jan. 22 in Diabetes Care.
Feb 4, 2021
0
6
(HealthDay)—From 1988 to 2018, there were reductions seen in the prevalence of albuminuria and improvements in glycemic, blood pressure, and lipid control among adults with newly diagnosed type 2 diabetes, according to ...
Jan 12, 2021
0
2
(HealthDay)—Among people with hypertension who are at high risk for cardiovascular disease (CVD), greater estimated glomerular filtration rate (eGFR) variability is independently associated with all-cause mortality, according ...
Jan 6, 2021
0
5
A recent analysis indicates that a drug shown previously to slow kidney disease progression is effective even in patients with advanced disease. The results appear in an upcoming issue of CJASN.
Nov 19, 2020
0
5
A new equation for estimating glomerular filtration rate, or GFR, a measure of kidney function, shows improved accuracy and precision compared with commonly used equations. Developed and tested by the European Kidney Function ...
Nov 10, 2020
0
8
Taking into account two common kidney disease tests may greatly enhance doctors' abilities to estimate patients' cardiovascular disease risks, enabling millions of patients to have better preventive cardiovascular care, according ...
Oct 14, 2020
0
2
(HealthDay)—Reducing urinary protein aids patients with the rare kidney disease focal segmental glomerulosclerosis (FSGS), according to a study published online Aug. 10 in the American Journal of Kidney Diseases.
Sep 11, 2020
0
4
Empagliflozin reduces the risk of cardiovascular death or hospitalization for heart failure in patients with heart failure and a reduced ejection fraction. That's the finding of the EMPEROR-Reduced trial presented in a Hot ...
Aug 31, 2020
0
6
